drugset / Trial / NCT00237497
Safety and Efficacy of Ramelteon in Adults With Chronic Insomnia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study is to evaluate the safety and efficacy of Ramelteon, once daily (QD), compared to placebo with Zopiclone in adults with chronic insomnia
Timeline
- Start
- 2005-07
- Primary completion
- 2006-10
- Completion
- 2006-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ramelteon | Unknown | 8 mg | Oral |
| Comparator | Zopiclone | Small molecule | 7.5 mg | Oral |
Indications
No indication recorded.